REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioavanz S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bioavanz S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioavanz S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 18, 2015. There are currently 2 (2023) people employed by Bioavanz S.A.. There was a net sales revenue increase of 183.89% reported in Bioavanz S.A.’s latest financial highlights for 2023. Over the same period, its total assets decreased by 43.11%. In 2023, Bioavanz S.A.’s net profit margin decreased by 36.43%.

Headquarters
Av. Rodrigo Chavez Solar 1, Empresarial Bldg. , Floor 7
Guayaquil; Guayas;

Contact Details: Purchase the Bioavanz S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Bioavanz S.A. report to view the information.
Outstanding Shares:
Purchase the Bioavanz S.A. report to view the information.
Registered Capital:
Purchase the Bioavanz S.A. report to view the information.
Incorporation Date:
March 18, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bioavanz S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
183.89%▲
Total operating revenue
41.95%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-323.6%▼
Total assets
-43.11%▼
Total equity
-12.18%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-36.43%▼
Return on Equity (ROE)
-23.1%▼
Debt to Equity Ratio
-26.67%▼
Quick Ratio
5.69%▲
Cash Ratio
0.18%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo